Skip to main content
SpringerLink
Log in

Bronchialkarzinom: Genetisches Screening vor Therapiebeginn

Lung cancer: genetic screening before starting therapy

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Mok TS, Wu YL, Thongprasert S et al. (2009) Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361: 958–967

    Article  Google Scholar 

  2. Sharma SV, Bell DW, Settleman J, Haber DA (2007) Epidemal growth factor receptor mutations in lung cancer. Nat Rev Cancer 7: 169–181

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt

Keine Angaben.

Author information

Authors and Affiliations

  1. Klinik I für Innere Medizin, Centrum für Integrierte Onkologie, Universitätsklinikum Köln, 50924, Köln, Deutschland

    J. Wolf

  2. Werl-Westönnen, Deutschland

    S. Nitschmann

Authors
  1. J. Wolf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Nitschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Wolf.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wolf, J., Nitschmann, S. Bronchialkarzinom: Genetisches Screening vor Therapiebeginn. Internist 51 (Suppl 1), 303–305 (2010). https://doi.org/10.1007/s00108-010-2600-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-010-2600-y

Search

Navigation